Haeundae paik hospital, inje university
Busan, 612-896, South Korea
NCT Number: NCT02455401
The purpose of this study is to compare the effect of remifentanil on postoperative vomiting in children undergoing strabismus surgery during sevoflurane anesthesia.
Looking for future studies?
Notify Me3 year–6 year
All sexes
Interventional
Not applicable
Busan, 612-896, South Korea
Children undergoing strabismus surgery frequently experience postoperative vomiting (POV) that results in dehydration, aspiration pneumonia, bleeding, delayed hospital discharge, as well as decreased parental satisfaction and an unpleasant experience for the pediatric patients. Although administration of perioperative opioids increases POV incidence, remifentanil has less affect the incidence of POV than other opioids such as fentanyl. However, there are few study that evaluate the effects of remifentanil on the incidence of POV. Therefore, the investigators will conducted the study that the effects of remifentanil on the incidence of POV in children undergoing strabismus surgery during sevoflurane anesthesia. One hundred five children from 3 to 6 yr of age, ASA physical status 1 or 2 were assigned randomly selected to one of three groups: high dose remifentanil group (bolus 1.0 mcg/kg; infusion 0.1 mcg/kg/min), low remifentanil group (bolus 0.5 mcg/kg; infusion 0.1 mcg/kg/min), or no remifentanil group (no remifentanil administration). Primary endpoint, the incidence of POV for 24 hours postoperatively, will be compared between three study groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention: continuously intravenous infusion of remifentanil 0.1 mcg/kg/min after bolus injection of remifentanil 1.0 mcg/kg for 2 minutes
Other names: High dose remifentanil (Ultiva,Glaxosmithkline, UK)
Intervention: continuously intravenous infusion of remifentanil 0.1 mcg/kg/min after bolus injection of remifentanil 0.5 mcg/kg for 2 minutes
Other names: Low dose remifentanil (Ultiva, Glaxosmithkline, UK)
Intervention: no remifentanil will be administrated
Other names: No remifentanil (Ultiva, Glaxosmithkline, UK)
Time frame: from extubation to 24 hours
Vomiting is expulsion of gastric contents. Incidence of vomiting will be compared between the groups.
Time frame: from extubation to 24 hours
Postoperative pain will be assessed using Faces Pain Rating Scale.
Time frame: from extubation to 24 hours
Postoperative emergence agitation will be assessed using Pediatric Anesthesia Emergence Delirium.
Inje University
Other
Effect of Remifentanil on Postoperative Vomiting in Children Undergoing Strabismus Surgery During Sevoflurane Anesthesia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03806400
Cranial Nerve Diseases, Eye Diseases
Hanzhou, Zhejiang, China
View Trial DetailsNCT06035757
Confusion, Cranial Nerve Diseases
Seoul, Seoul-T'ǔkpyǒlshi, South Korea
View Trial DetailsNCT07637253
Accomodation, Cranial Nerve Diseases
Istanbul, Basaksehir, Turkey (Türkiye)
View Trial DetailsNCT05882643
Cranial Nerve Diseases, Eye Diseases
Seoul, South Korea
View Trial Details